Assessing autonomic function in hypertrophic cardiomyopathy;Avaliação da função autonômica na cardiomiopatia hipertrófica

Arquivos Brasileiros de Cardiologia

Volumn 85, Issue 6, 2005, Pages 388-396

  Bittencourt, Marcelo Imbroinise ^a,b   Barbosa, Paulo Roberto Benchimol ^a   Neto, Cantídio Drumond ^a   Bedirian, Ricardo ^a   Barbosa, Eduardo Corrêa ^a   Brasil, Flavia ^a   Bomfim, Alfredo De Souza ^a   Albanesi Filho, Francisco Manes ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Autonomic nervous system (ANS); Heart rate (HR); Hypertrophic cardiomyopathy (HCM)

Indexed keywords

ADULT; ARTICLE; BREATHING; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART RATE VARIABILITY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; VAGUS NERVE STIMULATION; ADRENERGIC SYSTEM; ALGORITHM; AUTONOMIC NERVOUS SYSTEM; CASE CONTROL STUDY; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART RATE; MIDDLE AGED; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; ALGORITHMS; AUTONOMIC NERVOUS SYSTEM; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PARASYMPATHETIC NERVOUS SYSTEM; STATISTICS, NONPARAMETRIC; SYMPATHETIC NERVOUS SYSTEM;

EID: 33745490344     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2005001900004     Document Type: Article

References (33)

1. Maron BJ. Hypertrophic cardiomyopathy. Lancet. 1997; 350: 127-33.
2. Maron BJ, McKenna WJ, Danielson GK et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003; 42: 1687-713.
3. Goodwin JF. The frontiers of cardiomyopathy. Br Heart J. 1982; 48: 1-18.
4. Brush JE JR, Eisenhofer G, Garty M et al. Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy. Circulation. 1989; 79: 836-44.
5. Schafers M, Dutka D, Rhodes CG et al. Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy. Circ Res. 1998; 82: 57-62.
6. Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med. 1976; 294: 1165-70.
7. Schwartz PJ, Priori SG. Sympathetic nervous system and cardiac arrhythmias. In: Zipes DP, Jalife J (Eds.) Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, Pa: WB Saunders Co, 1990; 330-43.
8. Task force of the european society of cardiology the north american society of pacing electrophysiology. Heart Rate Variability.Standards of Measurement, Physiological Interpretation, and Clinical Use. Circulation. 1996; 93: 1043-65.
9. Wolf MM, Varigos GA, Hunt D et al. Sinus arrhythmia in acute myocardial infarction. Med J Aust 1978; 2: 52-3.
10. Odemuyiwa O, Malik M, Farrell T et al. Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction. Am J Cardiol. 1991; 68: 434-9.
11. Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med. 1980; 193: 95-108.
12. Smith S. Reduced sinus arrhythmia in diabetic autonomic neuropathy: diagnostic value of an age related normal range. Br Med J 1982; 285: 1599-601.
13. Malpas SC, Maling TJB. Heart rate variability and cardiac autonomic function in diabetes. Diabetes. 1990; 39: 1177-81.
14. Dreifus LS, Agarwal JB, Botvinick EH et al (American College of Cardiology Cardiovascular Technology Assessment Committee). Heart rate variability for risk stratification of life-threatening arrhythmias. J Am Coll Cardiol. 1993; 22: 948-50.
15. Inoue S, Nezuo S, Sawayama T et al. Autonomic function and severity of hypertrophic cardiomyopathy by power spectrum analysis on heart rate variability. Kokyu To Junkan. 1992; 40: 1209-13.(abstract).
16. Ajiki K, Murakawa Y, Yanagisawa-Miwa A et al. Autonomic nervous system activity in idiopathic dilated cardiomyopathy and in hypertrophic cardiomyopathy. Am J Cardiol. 1993; 71: 1316-20.
17. Uemura S, Tomoda Y, Fujimoto S et al. Heart rate variability and ventricular arrhythmia in clinically stable patients with hypertrophic cardiomyopathy. Jpn Circ J. 1997; 61: 819-26.
18. Bonaduce D, Petretta M, Betocchi S et al. Heart rate variability in patients with hypertrophic cardiomyopathy: association with clinical and echocardiographic features. Am Heart J. 1997; 134: 165-72.
19. Doven O, Sayin T, Guldal M et al. Heart rate variability in hypertrophic obstructive cardiomyopathy: association with functional classification and left ventricular outflow gradients. Int J Cardiol. 2001; 77: 281-6.
20. Fei L, Slade AK, Prasad K et al. Is there increased sympathetic activity in patients with hypertrophic cardiomyopathy? J Am Coll Cardiol. 1995; 26: 472-80.
21. Limbruno U, Strata G, Mengozzi G et al. Spectrum analysis of heart rate variability in obstructive hypertrophic myocardiopathy. Evidence of altered autonomic function. Cardiologia. 1992; 37: 847-52.
22. Limbruno U, Strata G, Zucchi R et al. Altered autonomic cardiac control in hypertrophic cardiomyopathy. Role of outflow tract obstruction and myocardial hypertrophy. Eur Heart J. 1998; 19: 146-53.
23. Maron BJ. Hypertrophic Cardiomyopathy: A Systematic Review. JAMA. 2002; 287: 1308-20.
24. Henry WL, Demaria A, Gramiak R et al. Report of the American Society of Echocardiography Committee on nomenclature and standards in two-dimensional echocardiography. Circulation. 1980; 62: 212-5.
25. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989; 2: 358-67.
26. Gilligan DM, Chan WL, Sbarouni E et al. Autonomic function in hypertrophic cardiomyopathy. Br Heart J. 1993; 69: 525-9.
27. Barbosa Filho J, Barbosa PRB, Cordovil I. Modulação autonômica do coração na Hipertensão arterial sistêmica. Arq Bras Cardiol. 2002; 78: 181-8.
28. McKenna WJ, Behr ER. Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death. Heart. 2002; 87: 169-76.
29. Fananapazir L, Chang AC, Epstein SE et al. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and eletrophysiological findings. Circulation. 1992; 86: 730-40.
30. Counihan PJ, Fei L, Bashir Y et al. Assessment of heart rate variability in hypertrophic cardiomyopathy. Association with clinical and prognostic features. Circulation. 1993; 8: 1682-90.
31. Tanabe T. Impaired heart rate variability in patients with symptomatic NYHA class II-III hypertrophic cardiomyopathy. Rinsho Byori. 1998; 46: 1030-6. (abstract).
32. Jimenez AA, Luengo CM, Jimenez AS, et al. Appraisal of the state of the autonomic nervous system in hypertrophic cardiomyopathy by the analysis of heart rate variability. Rev Esp Cardiol. 1998; 51: 286-91.
33. Gilligan DM, Nihoyannopoulos P, Chan WL et al. Investigation of a hemodynamic basis for syncope in hypertrophic cardiomyopathy. Use of a head-up tilt test. Circulation. 1992; 85: 2140-8.